Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial.
Analysis of 107 patients with cirrhosis and recent variceal haemorrhage included in a prospective randomised trial of endoscopic injection sclerotherapy showed that in the sclerotherapy group 22 (43%) of the 51 patients had episodes of haemorrhage during the period of treatment, but in only 4 did bleeding occur after the varices had been obliterated. This contrasts with episodes of bleeding in 42 (75%) of the 56 patients receiving standard medical management-a highly significant difference. The overall risk of bleeding per patient-month of follow-up was reduced threefold with sclerotherapy. Of 22 patients followed up for at least one year after obliteration of varices, 14 had no evidence of reappearance of varices within this period and, by means of cumulative life-analysis tables, survival was shown to be significantly improved in the sclerotherapy group.
D002986:Clinical Trials as Topic; D004935:Esophageal Diseases / Q000209:etiology; D004940:Esophageal Stenosis / Q000209:etiology; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000188:drug therapy*; D004945:Esophagoscopy / Q000009:adverse effects; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D007267:Injections; D008104:Liver Cirrhosis, Alcoholic / Q000150:complications; D008297:Male; D011446:Prospective Studies; D011897:Random Allocation; D012597:Sclerosing Solutions / Q000008:administration & dosage* / Q000627:therapeutic use*; D014456:Ulcer / Q000209:etiology
D012597:Sclerosing Solutions